Compound 1051
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(O)=O)c1c2[nH]n(-c2cccc(F)c2)c1=O
- InChi:
InChI=1S/C21H14FN5O3/c1-26-19-15(10-23-26)18-16(17(24-19)11-4-2-5-12(8-11)21(29)30)20(28)27(25-18)14-7-3-6-13(22)9-14/h2-10,25H,1H3,(H,29,30)
- InChiKey:
TYLLBOCDKUXAKC-UHFFFAOYSA-N
External links
168318099 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.14 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 403.11 g/mol | |||
HBA | 8 | |||
HBD | 2 | |||
HBA + HBD | 10 | |||
AlogP | 3.91 | |||
TPSA | 100.35 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5021 | Riociguat | DB08931 | |
0.4857 | Vericiguat | DB15456 | |
0.4703 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4698 | Dilmapimod | DB12140 | |
0.4693 | ATX-914 | DB12673 | |
0.4590 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4585 | Merestinib | DB12381 | |
0.4462 | Risdiplam | DB15305 | |
0.4434 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4430 | Tepotinib | DB15133 | |
0.4358 | Telmisartan | DB00966 | |
0.4340 | Ravoxertinib | DB15281 | |
0.4312 | 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide | DB08583 | |
0.4292 | 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | DB08054 | |
0.4291 | TAS-116 | DB14876 |